A detailed history of Krensavage Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Krensavage Asset Management, LLC holds 353 shares of REGN stock, worth $247,753. This represents 0.21% of its overall portfolio holdings.

Number of Shares
353
Previous 7,853 95.5%
Holding current value
$247,753
Previous $8.25 Million 95.51%
% of portfolio
0.21%
Previous 3.79%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1024.09 - $1201.76 $7.68 Million - $9.01 Million
-7,500 Reduced 95.5%
353 $371,000
Q2 2024

Aug 14, 2024

SELL
$883.2 - $1071.19 $4.1 Million - $4.97 Million
-4,641 Reduced 37.15%
7,853 $8.25 Million
Q1 2024

May 15, 2024

SELL
$902.69 - $993.35 $31.4 Million - $34.5 Million
-34,762 Reduced 73.56%
12,494 $12 Million
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $8.26 Million - $10.1 Million
-11,932 Reduced 20.16%
47,256 $38.9 Million
Q2 2023

Aug 11, 2023

SELL
$700.03 - $830.35 $210,009 - $249,105
-300 Reduced 0.5%
59,188 $42.5 Million
Q1 2023

May 15, 2023

SELL
$680.49 - $826.97 $418,501 - $508,586
-615 Reduced 1.02%
59,488 $48.9 Million
Q4 2022

Feb 15, 2023

SELL
$705.89 - $766.39 $554,829 - $602,382
-786 Reduced 1.29%
60,103 $43.4 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $289,854 - $365,781
505 Added 0.84%
60,889 $41.9 Million
Q2 2022

Aug 16, 2022

SELL
$548.35 - $738.84 $3.56 Million - $4.8 Million
-6,496 Reduced 9.71%
60,384 $35.7 Million
Q1 2022

May 17, 2022

SELL
$595.12 - $698.43 $1.31 Million - $1.54 Million
-2,200 Reduced 3.18%
66,880 $46.7 Million
Q4 2021

Feb 15, 2022

SELL
$543.48 - $670.97 $2.21 Million - $2.73 Million
-4,063 Reduced 5.55%
69,080 $43.6 Million
Q3 2021

Nov 16, 2021

SELL
$574.03 - $680.96 $5.14 Million - $6.1 Million
-8,961 Reduced 10.91%
73,143 $44.3 Million
Q2 2021

Aug 13, 2021

SELL
$472.8 - $558.54 $280,843 - $331,772
-594 Reduced 0.72%
82,104 $45.9 Million
Q1 2021

May 18, 2021

BUY
$446.73 - $548.2 $222,471 - $273,003
498 Added 0.61%
82,698 $39.1 Million
Q4 2020

Feb 17, 2021

SELL
$478.3 - $607.98 $27,741 - $35,262
-58 Reduced 0.07%
82,200 $39.7 Million
Q3 2020

Nov 17, 2020

BUY
$544.75 - $658.21 $1.4 Million - $1.69 Million
2,567 Added 3.22%
82,258 $46 Million
Q2 2020

Aug 17, 2020

SELL
$493.32 - $643.92 $3.52 Million - $4.59 Million
-7,126 Reduced 8.21%
79,691 $49.7 Million
Q1 2020

May 18, 2020

SELL
$336.18 - $494.43 $5.92 Million - $8.7 Million
-17,603 Reduced 16.86%
86,817 $42.4 Million
Q4 2019

Feb 18, 2020

BUY
$274.13 - $376.51 $28.6 Million - $39.3 Million
104,420 New
104,420 $39.2 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Krensavage Asset Management, LLC Portfolio

Follow Krensavage Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krensavage Asset Management, LLC with notifications on news.